HC Wainwright reaffirmed their buy rating on shares of Nyxoah (NASDAQ:NYXH – Free Report) in a research report released on Monday morning, Benzinga reports. They currently have a $18.00 price objective on the stock. A number of other research firms also recently commented on NYXH. Cantor Fitzgerald dropped their price objective on Nyxoah from $17.00 […]

HC Wainwright reissued their buy rating on shares of AEON Biopharma (NASDAQ:AEON – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a $5.00 price target on the stock. AEON Biopharma Trading Down 2.7 % Shares of AEON stock opened at $1.10 on Tuesday. AEON Biopharma has […]

Legend Biotech (NASDAQ:LEGN – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research note issued to investors on Monday, Benzinga reports. They presently have a $73.00 price objective on the stock. HC Wainwright’s price target suggests a potential upside of 53.75% from the stock’s current price. A […]

Benitec Biopharma (NASDAQ:BNTC – Get Free Report)‘s stock had its “market outperform” rating reiterated by investment analysts at JMP Securities in a research note issued on Monday, Benzinga reports. They currently have a $16.00 target price on the biotechnology company’s stock. JMP Securities’ price objective indicates a potential upside of 45.79% from the stock’s previous […]